Novo CEO pressed by Senate to chop costs of weight problems, diabetes medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the company would contemplate new talks with insurers with regard to the record costs of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. Financial https://dave-s-hot-chicken-calori87532.actoblog.com/31251744/everything-about-healthcare-news